Lakewood-Amedex Biotherapeutics Reports Nu-3 Data And Completes Key Manufacturing Milestones Ahead Of Planned Phase 2 Trial For Diabetic Foot Ulcer Treatment

Benzinga Newsdesk www.benzinga.com Positive 85.4%

Neg 0% Neu 0% Pos 85.4%

Comments

No comments yet. Be the first!